Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model

Human Molecular Genetics

Volumn 20, Issue 6, 2011, Pages 1182-1196

  Ricciardi, Sara ^a   Boggio, Elena M ^b,c   Grosso, Stefano ^a,d   Lonetti, Giuseppina ^e   Forlani, Greta ^f   Stefanelli, Gilda ^a   Calcagno, Eleonora ^b   Morello, Noemi ^b   Landsberger, Nicoletta ^a,f   Biffo, Stefano ^a,d   Pizzorusso, Tommaso ^c,e   Giustetto, Maurizio ^b   Broccoli, Vania ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MAMMALIAN TARGET OF RAPAMYCIN; METHYL CPG BINDING PROTEIN 2; PROTEIN S6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; GENE DISRUPTION; GENE FUNCTION; GENE MUTATION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; MUTANT; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RETT SYNDROME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; ONCOGENE PROTEIN V-AKT; PROTEIN BIOSYNTHESIS; RETT SYNDROME; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

ANIMALIA; MAMMALIA;

EID: 79952032711     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq563     Document Type: Article

References (61)

1. Bienvenu, T. and Chelly, J. (2006) Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat. Rev. Genet., 7, 415-426.
2. Chahrour, M. and Zoghbi, H.Y. (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron, 56, 422-437.
3. Tao, J., Wu, H. and Sun, Y.E. (2009) Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons. Int. Rev. Neurobiol., 89, 147-160.
4. Hagberg, B. (2002) Clinical manifestations and stages of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev., 8, 61-65.
5. Nan, X., Ng, H.H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N. and Bird, A. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393, 386-389.
6. Francke, U. (2006) Mechanisms of disease: neurogenetics of MeCP2 deficiency. Nat. Clin. Pract. Neurol., 2, 212-221.
7. Lasalle, J.M. and Yasui, D.H. (2009) Evolving role of MeCP2 in Rett syndrome and autism. Epigenomics, 1, 119-130.
8. Chen, R.Z., Akbarian, S., Tudor, M. and Jaenisch, R. (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet., 27, 327-331.
9. Guy, J., Hendrich, B., Holmes, M., Martin, J.E. and Bird, A. (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet., 27, 322-326.
10. Dani, V.S., Chang, Q., Maffei, A., Turrigiano, G.G., Jaenisch, R. and Nelson, S.B. (2005) Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA, 102, 12560-12565.
11. Kishi, N. and Macklis, J.D. (2005) Dissecting MECP2 function in the central nervous system. J. Child Neurol., 20, 753-759.
12. Moretti, P. and Zoghbi, H.Y. (2006) MeCP2 dysfunction in Rett syndrome and related disorders. Curr. Opin. Genet. Dev., 16, 276-281.
13. Chao, H.T., Zoghbi, H.Y. and Rosenmund, C. (2007) MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron, 56, 58-65.
14. Monteggia, L.M. and Kavalali, E.T. (2009) Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission. Biol. Psychiatry, 65, 204-210.
15. Tropea, D., Giacometti, E., Wilson, N.R., Beard, C., McCurry, C., Fu, D.D., Flannery, R., Jaenisch, R. and Sur, M. (2009) Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proc. Natl Acad. Sci. USA, 106, 2029-2034.
16. Boggio, E.M., Lonetti, G., Pizzorusso, T. and Giustetto, M. (2010) Synaptic determinants of Rett syndrome. Front. Syn. Neurosci., 2, 1-12.
17. Kelleher, R.J. III and Bear, M.F. (2008) The autistic neuron: troubled translation? Cell, 135, 401-406.
18. Bourgeron, T. (2009) A synaptic trek to autism. Curr. Opin. Neurobiol., 19, 231-234.
19. Krab, L.C., Goorden, S.M. and Elgersma, Y. (2008) Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases. Trends Genet., 24, 498-510.
20. Hoeffer, C.A. and Klann, E. (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci., 33, 67-75.
21. Bear, M.F., Dölen, G., Osterweil, E. and Nagarajan, N. (2008) Fragile X: translation in action. Neuropsychopharmacology, 33, 84-87.
22. Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D.J., Ramesh, V. and Silva, A.J. (2008) Reversal of learning deficits in a Tsc2+/2 mouse model of tuberous sclerosis. Nat. Med., 14, 843-848.
23. Schmidt, H., Ker, W., Giese, R., Hallschmid, M. and Enders, A. (2009) Intranasal insulin to improve developmental delay in children with 22q13deletion syndrome: an exploratory clinical trial. J. Med. Genet., 46, 217-222.
24. Kelleher, R.J. 3rd, Govindarajan, A. and Tonegawa, S. (2004) Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron, 44, 59-73.
25. Jaworski, J. and Sheng, M. (2006) The growing role of mTOR in neuronal development and plasticity. Mol. Neurobiol., 34, 205-219.
26. Richter, J.D. and Klann, E. (2009) Making synaptic plasticity and memory last: mechanisms of translational regulation. Genes Dev., 23, 1-11.
27. Jordan, C., Li, H.H., Kwan, H.C. and Francke, U. (2007) Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med. Genet., 8, 36.
28. Urdinguio, R.G., Lopez-Serra, L., Lopez-Nieva, P., Alaminos, M., Diaz-Uriarte, R., Fernandez, A.F. and Esteller, M. (2008) Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One, 3, e3669.
29. Pende, M., Um, S.H., Mieulet, V., Sticker, M., Goss, V.L., Mestan, J., Mueller, M., Fumagalli, S., Kozma, S.C. and Thomas, G. (2004) S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol. Cell. Biol., 243, 112-124.
30. Ruvinsky, I. and Meyuhas, O. (2006) Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem. Sci., 31, 342-348.
31. Roux, P.P. et al. (2007) RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J. Biol. Chem., 282, 14056-1464.
32. Banko, J.L., Hou, L. and Klann, E. (2004) NMDA receptor activation results in PKA- and ERK-dependent Mnk1 activation and increased eIF4E phosphorylation in hippocampal area CA1. J. Neurochem., 91, 462-470.
33. Banko, J.L., Hou, L., Poulin, F., Sonenberg, N. and Klann, E. (2006) Regulation of eukaryotic initiation factor 4E by converging signaling pathways during metabotropic glutamate receptor-dependent long-term depression. J. Neurosci., 26, 2167-2173.
34. Fukuda, T., Itoh, M., Ichikawa, T., Washiyama, K. and Goto, Y. (2005) Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J. Neuropathol. Exp. Neurol., 64, 537-544.
35. Belichenko, N.P., Belichenko, P.V. and Mobley, W.C. (2009a) Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Neurobiol. Dis., 34, 71-77.
36. Belichenko, P.V., Wright, E.E., Belichenko, N.P., Masliah, E., Li, H.H., Mobley, W.C. and Francke, U. (2009b) Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J. Comp. Neurol., 514, 240-258.
37. Lonetti, G., Angelucci, A., Morando, L., Boggio, E.M., Giustetto, M. and Pizzorusso, T. (2010) Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol. Psychiatry, 67, 657-665.
38. Ballas, N., Lioy, D.T., Grunseich, C. and Mandel, G. (2009) Non-cell autonomous influence of MeCP2 deficient glia on neuronal dendritic morphology. Nat. Neurosci., 12, 311-317.
39. Grosso, S., Volta, V., Sala, L.A., Vietri, M., Marchisio, P.C., Ron, D. and Biffo, S. (2008) PKCbetaII modulates translation independently from mTOR and through RACK1. Biochem. J., 415, 77-85.
40. Dufner, A. and Thomas, G. (1999) Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res., 253, 100-109.
41. Hay, N. and Sonenberg, N. (2004) Upstream and downstream of mTOR. Genes Dev., 18, 1926-1945.
42. Ma, X.M. and Blenis, J. (2009) Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol., 10, 307-318.
43. Sarbassov, D.D., Guertin, D.A., Ali, S.M. and Sabatini, D.M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science, 307, 1098-1101.
44. LaSalle, J., Goldstine, J., Balmer, D. and Greco, C. (2001) Quantitative localization of heterologous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum. Mol. Genet., 10, 1729-1740.
45. Ballas, N., Lioy, D.T., Grunseich, C. and Mandel, G. (2209) Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat. Neurosci., 12, 311-317.
46. Maezawa, I., Swanberg, S., Harvey, D., LaSalle, J.M. and Jin, L.W. (2009) Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J. Neurosci., 29, 5051-5061.
47. Zoghbi, H.Y. (2009) Rett syndrome: what do we know for sure? Nat. Neurosci., 12, 239-240.
48. Maezawa, I. and Jin, L.W. (2010) Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J. Neurosci., 30, 5346-5356.
49. Costa-Mattioli, M., Sossin, W.S., Klann, E. and Sonenberg, N. (2009) Translational control of long-lasting synaptic plasticity and memory. Neuron, 61, 10-26.
50. Laplante, M. and Sabatini, D.M. (2009) mTOR signaling at a glance. J. Cell Sci., 122, 3589-3594.
51. Skene, P.J., Illingworth, R.S., Webb, S., Kerr, A.R., James, K.D., Turner, D.J., Andrews, R. and Bird, A.P. (2010) Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell., 37, 457-468.
52. Fyffe, S.L., Neul, J.L., Samaco, R.C., Chao, H.T., Ben-Shachar, S., Moretti, P., McGill, B.E., Goulding, E.H., Sullivan, E., Tecott, L.H. et al. (2008) Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron, 59, 947-958.
53. Shahbazian, M.D., Antalffy, B., Armstrong, D.L. and Zoghbi, H.Y. (2002) Insight into Rett syndrome: MeCP2 levels display tissue- and cell- specific differences and correlate with neuronal maturation. Hum. Mol. Genet., 11, 115-124.
54. Thatcher, K.N. and LaSalle, J.M. (2006) Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2. Epigenetics, 1, 24-31.
55. Marchi, M., Guarda, A., Bergo, A., Landsberger, N., Kilstrup-Nielsen, C., Ratto, G.M. and Costa, M. (2007) Spatio-temporal dynamics and localization of MeCP2 and pathological mutants in living cells. Epigenetics, 2, 187-197.
56. Sonenberg, N. and Hinnebusch, A.G. (2009) Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell, 136, 731-745.
57. Young, J.I., Hong, E.P., Castle, J.C., Crespo-Barreto, J., Bowman, A.B., Rose, M.F., Kang, D., Richman, R., Johnson, J.M., Berget, S. et al. (2005) Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl Acad. Sci. USA, 102, 17551-17558.
58. Boggio, E.M., Putignano, E., Sassoe-Pognetto, M., Pizzorusso, T. and Giustetto, M. (2007) Visual stimulation activates ERK in synaptic and somatic compartments of rat cortical neurons with parallel kinetics. PLoS One, 2, e604.
59. Vara, H., Onofri, F., Benfenati, F., Sassoe'-Pognetto, M. and Giustetto, M. (2009) ERK activation in axonal varicosities modulates presynaptic plasticity in the CA3 region of the hippocampus through synapsin I. Proc. Natl Acad. Sci. USA, 106, 9872-9877.
60. Ceci, M., Gaviraghi, C., Gorrini, C., Sala, L.A., Offenhäuser, N., Marchisio, P.C. and Biffo, S. (2003) Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly. Nature, 426, 579-584.
61. Kishi, N. and Macklis, J.D. (2004) MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol. Cell. Neurosci., 27, 306-321.